Literature DB >> 833750

Absorption, distribution, and excretion of 14C-meglumine in rats and dogs after administration of 14C-meglumine salicylate.

J F Heeg, G S Born, W V Kessler, S M Shaw, W E Lange.   

Abstract

Meglumine labeled with carbon-14 was administered orally as 14C-meglumine salicylate to rats and dogs to study its distribution and excretion. The compound was incompletely absorbed; that which was absorbed was rapidly excreted in the urine. Peak blood levels were about 5-10 mug/ml in rats and 2-8 mug/ml in dogs. Tissue levels were negligible at the end of the experimental periods. No evidence for N-demethylation or oxidation to carbon dioxide was obtained.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833750     DOI: 10.1002/jps.2600660124

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes.

Authors:  Arturo Bravo-Nuevo; Alice Marcy; Minzhou Huang; Frank Kappler; Jennifer Mulgrew; Lisa Laury-Kleintop; Melvin Reichman; Annette Tobia; George C Prendergast
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.